Cancer
Overview
QUT’s Cancer Program combines the activities of multidisciplinary research teams with the aim of improving outcomes for cancer patients.
We operate a strong collaborative research model where molecular and cellular biologists work alongside bioinformaticians, medicinal chemists, surgeons, oncologists and industrial partners to provide a real bench-to-bedside approach to tackling this disease.
Programs
- Prostate Cancer
- Breast Cancer
- Ovarian Cancer
- Endometrial Cancer
- Lung Cancer
- Melanoma.
Researchers within this group have expertise in:
- gene expression
- regulation
- animal models
- imaging
- steroid hormones
- molecular endocrinology
- targeted therapeutics.
The focus is on the development of new therapeutics and predictive biomarkers for cancer, via a collaborative, transdisciplinary and translational approach.
Projects
This is just a sample of our research activity in this area.
- Ghrelin Research Group
- Bone Biology Program
- Hormone Dependent Cancer
- Development of Cancer Survivor Self-management Plans
- Investigating the relationship between Bone Marrow Composition and Bone Tissue Quality
- An Evaluation of the Statewide Cancer Care Coordination Program
- The function and signalling mechanisms of Ghrelin and the Ghrelin-Gene Derived Hormone, Obestatin, in Prostate, Breast, Ovarian and Colon Cancer cell proliferation, metabolism and migration
- Evaluating non-pharmacological interventions for people with lung cancer
- Australian Prostate Cancer Research Centre - Queensland (APCRC-Q)
- A two-stage trial of antiemetic therapy in patients with cancer and nausea not related to anticancer therapy
- Development of an Interactive Training Module for Health Professionals to Address the Psychosexual Care of Women Affected by Gynaecological Cancers
Research enquiries
Health Research Services
- Phone: 3138 8290
- Int. phone: +61 7 3138 8290
- Email: health.research@qut.edu.au
